SEB Bioteknikfond D vs Nordnet Indexfond Global

SEB Bioteknikfond D vs Nordnet Indexfond Global

1. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

2. Nordnet Indexfond Global

  • Security

    Nordnet Indexfond Global ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2G30

  • Holdings

    10

  • Number of owning funds

    2

Fund Holdings

We have information about 24 holdings in SEB Bioteknikfond D, where the largest holding is Gilead Sciences (10.04), followed by Vertex (8.8) and Amgen (8.54). In comparison with Nordnet Indexfond Global, we have 22 holdings where Salesforce.com is the largest holding (0.78), followed by AstraZeneca (0.64) and Merck & Co (0.64).

All Holdings

Here we compare the holdings in SEB Bioteknikfond D and Nordnet Indexfond Global.

SEB Bioteknikfond D Nordnet Indexfond Global
1. Gilead Sciences Inc
USA
10.04 %
1. Salesforce.com Inc
USA
0.78 %
2. Vertex Pharmaceuticals Inc
8.8 %
2. AstraZeneca
Sweden UK
0.64 %
3. Amgen Inc
8.54 %
3. Merck & Co Inc
Germany
0.64 %
4. Regeneron Pharmaceuticals Inc
5.09 %
4. IBM Corp
USA
0.64 %
5. Alnylam Pharmaceuticals Inc
5.07 %
5. GE Aerospace
USA
0.62 %
6. AstraZeneca ADR
Sweden UK
4.49 %
6. McDonald's Corp
USA
0.61 %
7. Verona Pharma ADR
3.46 %
7. Linde Plc
Ireland
0.61 %
8. Argenx ADR
2.72 %
8. Accenture Plc
Ireland
0.6 %
9. Illumina Inc
2.72 %
9. HSBC Holdings PLC
UK
0.59 %
10. BioNTech SE
2.41 %
10. PepsiCo Inc
USA
0.58 %
11. Madrigal Pharmaceuticals Inc
1.88 %
-
12. BoneSupport AB
Sweden
1.82 %
-
13. BioMarin Pharmaceutical Inc
1.7 %
-
14. Krystal Biotech Inc
1.48 %
-
15. NewAmsterdam Pharma NV
1.46 %
-
16. BridgeBio Pharma Inc
1.45 %
-
17. Cytokinetics Inc
1.4 %
-
18. Ionis Pharmaceuticals Inc
1.37 %
-
19. Xenon Pharmaceuticals
1.37 %
-
20. Insmed Inc
1.32 %
-
21. Onward Medical NV
1.31 %
-
22. Janux Therapeutics Inc
1.3 %
-
23. Structure Therapeutics ADR
1.24 %
-
24. Kymera Therapeutics Inc
1.09 %
-

The list of fund holdings was last updated on April 17, 2025.